Phospho-STAT1 (S727) Antibody

What is Phospho-STAT1 (S727) Antibody and what specifically does it detect?

Phospho-STAT1 (S727) Antibody detects endogenous levels of STAT1 protein only when phosphorylated at the Serine 727 position. Importantly, this antibody specifically detects the STAT1α isoform, as the Ser727 site is deleted in the STAT1β isoform . The antibody recognizes a phosphopeptide corresponding to amino acid residues surrounding S727 of human STAT1 . This specificity makes it valuable for distinguishing the activation state of STAT1 in various signaling pathways, particularly those related to interferon responses.

What are the recommended applications and dilutions for Phospho-STAT1 (S727) Antibody?

Phospho-STAT1 (S727) Antibody has multiple validated applications with specific recommended dilutions:

For optimal ChIP results, using 10 μl of antibody with 10 μg of chromatin (approximately 4 × 10^6 cells) per immunoprecipitation is recommended. The antibody has been validated using SimpleChIP Enzymatic Chromatin IP Kits .

What controls should be included when using Phospho-STAT1 (S727) Antibody?

When using Phospho-STAT1 (S727) Antibody, several controls are essential for experimental validation:

• Positive controls: Use interferon-treated samples as positive controls. IFN-gamma treated HeLa cells have been validated for Western blot applications, while IFN-alpha treated HeLa cells work well for immunofluorescence applications .

• Negative controls: Include unstimulated cells or tissue as negative controls since basal phosphorylation is typically low.

• Specificity controls: To confirm antibody specificity, consider using STAT1 knockout cells or STAT1 S727A mutant cells (where serine is replaced with alanine to prevent phosphorylation).

• Loading controls: Include appropriate loading controls for Western blotting, such as antibodies against total STAT1 or housekeeping proteins.

How should Phospho-STAT1 (S727) Antibody be stored for optimal performance?

For short-term storage (up to 2 weeks), Phospho-STAT1 (S727) Antibody should be refrigerated at 2-8°C. For long-term storage, the antibody should be kept at -20°C in small aliquots to prevent freeze-thaw cycles that could degrade the antibody . The antibody is typically supplied in PBS with 0.09% (W/V) sodium azide as a preservative .

What is the relationship between Y701 and S727 phosphorylation in STAT1 activation?

The relationship between Y701 and S727 phosphorylation is crucial for understanding STAT1 activation:

• Y701 phosphorylation is required for STAT1 dimerization and nuclear translocation.

• S727 phosphorylation is necessary for full transcriptional activity and biological function of STAT1.

• Research has demonstrated that both STAT1 Y701 phosphorylation and nuclear translocation are prerequisites for IFN-induced S727 phosphorylation .

• Experiments with STAT1 mutants lacking Y701 phosphorylation (Y701F) showed that these mutants fail to undergo S727 phosphorylation in response to interferons, even when artificially localized to the nucleus using an SV40 nuclear localization signal (NLS) .

This sequential phosphorylation mechanism ensures proper activation of STAT1-mediated transcriptional responses.

How does chromatin association affect STAT1 S727 phosphorylation?

Chromatin association plays a critical role in STAT1 S727 phosphorylation:

• STAT1 mutants lacking the ability to stably associate with chromatin are poorly serine-phosphorylated in response to IFN-γ .

• Studies with Stat1 mutants (K336A, K544A/E545A, and N460A) that have diminished DNA binding capability showed inefficient S727 phosphorylation upon IFN-γ treatment despite nuclear accumulation .

• S727 phosphorylation of DNA binding-deficient mutants can be restored upon IFN-β treatment, which induces formation of the ISGF3 complex (Stat1/Stat2/Irf9) where Irf9 serves as the main DNA binding subunit .

• This mechanism indicates that STAT1 must be assembled into chromatin-associated transcriptional complexes to become S727-phosphorylated and fully biologically active in response to interferons .

This control mechanism restricts the final activation step to the chromatin-tethered transcription factor, ensuring proper regulation of gene expression.

How do different interferons affect STAT1 S727 phosphorylation patterns?

Different interferons induce distinct patterns of STAT1 S727 phosphorylation:

• IFN-γ (Type II interferon): Requires both Y701 phosphorylation and stable DNA binding of STAT1 for efficient S727 phosphorylation. STAT1 mutants with defective DNA binding show poor S727 phosphorylation in response to IFN-γ .

• IFN-α/β (Type I interferons): Can induce normal S727 phosphorylation even in STAT1 mutants with reduced chromatin association. This is because type I interferons promote formation of the ISGF3 complex, where STAT1 maintains transcriptional activity through association with IRF9, which provides the DNA binding capability .

• Time kinetics: The kinetics of S727 phosphorylation and nuclear translocation are consistent with the model that chromatin association is required for S727 phosphorylation .

Understanding these differential responses can help researchers design more precise experiments when studying interferon signaling pathways.

How does stress-induced STAT1 S727 phosphorylation differ from IFN-induced phosphorylation?

Stress-induced and IFN-induced STAT1 S727 phosphorylation occur through distinct mechanisms:

• Stress-induced phosphorylation: Mediated by p38 MAPK, this pathway does not require Y701 phosphorylation or nuclear localization of STAT1. Stress inducers like anisomycin can cause S727 phosphorylation of STAT1 regardless of Y701 phosphorylation status or nuclear localization .

• IFN-induced phosphorylation: Requires Y701 phosphorylation, nuclear localization, and stable association with chromatin (for IFN-γ) or integration into ISGF3 complex (for IFN-α/β) .

• Experimental validation: Studies have shown that anisomycin treatment causes S727 phosphorylation of both wild-type STAT1 and Y701F mutants, while IFN-γ increases the pS727 signal only in the wild-type but not in Y701F mutants .

This distinction is important when designing experiments to study STAT1 activation in different cellular contexts.

What are the optimal conditions for Western blotting with Phospho-STAT1 (S727) Antibody?

For optimal Western blotting results with Phospho-STAT1 (S727) Antibody:

• Sample preparation: Use freshly prepared cell lysates from interferon-stimulated cells. HeLa cells treated with IFN-gamma are confirmed to work well as positive controls .

• Expected molecular weight: The observed molecular weight of phosphorylated STAT1 is approximately 84-91 kDa .

• Blocking conditions: Use 5% BSA in TBST for blocking and antibody dilution to reduce background and enhance specific signal.

• Exposure time: Start with standard exposure times and adjust as needed. Over-exposure may lead to background issues.

• Stripping and reprobing: For comparing phosphorylated and total STAT1 levels, consider using parallel blots rather than stripping and reprobing, as stripping can sometimes reduce the phospho-epitope signal.

How can I optimize ChIP protocols using Phospho-STAT1 (S727) Antibody?

For effective ChIP experiments using Phospho-STAT1 (S727) Antibody:

• Antibody amount: Use 10 μl of antibody per ChIP reaction with 10 μg of chromatin (approximately 4 × 10^6 cells) .

• Crosslinking: Optimize crosslinking time based on your cell type. Excessive crosslinking can reduce antibody accessibility to epitopes.

• Sonication: Ensure chromatin is sonicated to fragments of 200-500 bp for optimal antibody access and resolution.

• Controls: Include a non-specific IgG control and a positive control antibody targeting a known abundant chromatin-associated protein.

• Target genes: Focus on known STAT1 target genes with established GAS (Gamma-Activated Sequence) elements for validation experiments.

• Enzymatic shearing: Consider using enzymatic chromatin preparation kits, as the antibody has been validated using SimpleChIP Enzymatic Chromatin IP Kits .

What are common challenges in detecting phosphorylated STAT1 S727 in different cell types?

Researchers may encounter several challenges when detecting phosphorylated STAT1 S727:

• Basal phosphorylation levels: Different cell types exhibit varying levels of basal S727 phosphorylation, making it crucial to include appropriate positive controls.

• Signaling kinetics: The timing of S727 phosphorylation may vary between cell types and stimuli. Conduct time-course experiments to determine optimal stimulation times.

• Phosphatase activity: Rapid dephosphorylation may occur during sample preparation. Include phosphatase inhibitors in lysis buffers to preserve phosphorylation status.

• Antibody cross-reactivity: While the antibody is specifically designed for human STAT1 pS727, it may exhibit cross-reactivity with mouse and rat samples due to sequence homology , though this should be empirically verified.

• Non-specific bands: Some cell types may show non-specific bands in Western blots. Verify specificity using STAT1 knockout or knockdown controls.

What is the functional significance of STAT1 S727 phosphorylation in gene transcription?

STAT1 S727 phosphorylation plays crucial roles in gene transcription:

• Transcriptional enhancement: S727 phosphorylation is required for full transcriptional activity of STAT1, even when Y701 phosphorylation and DNA binding are intact .

• Selective gene regulation: S727 phosphorylation may differentially regulate subsets of STAT1-dependent genes, providing an additional layer of signaling specificity.

• Co-activator recruitment: Phosphorylation at S727 facilitates the recruitment of transcriptional co-activators and components of the basal transcription machinery.

• Integration of signals: As S727 can be phosphorylated through different pathways (IFN-dependent and stress-induced), this modification may integrate multiple signaling inputs at the chromatin level.

• Temporal regulation: The requirement for chromatin association prior to S727 phosphorylation suggests this serves as a regulatory checkpoint, ensuring that only properly assembled transcriptional complexes become fully activated .

How can Phospho-STAT1 (S727) Antibody be used to study cross-talk between different signaling pathways?

Phospho-STAT1 (S727) Antibody is valuable for studying signaling cross-talk:

• Interferon and stress pathway integration: By monitoring S727 phosphorylation in response to interferons, stress stimuli, or their combination, researchers can investigate how these pathways converge on STAT1.

• Multiple kinase involvement: Different kinases can phosphorylate S727 in response to various stimuli. Using specific kinase inhibitors alongside Phospho-STAT1 (S727) Antibody can help delineate these pathways.

• Temporal signaling patterns: Time-course experiments with different stimuli can reveal how various signaling inputs are integrated and prioritized at the level of STAT1 activation.

• Co-immunoprecipitation studies: Combining Phospho-STAT1 (S727) Antibody with co-IP approaches can identify proteins that specifically interact with the S727-phosphorylated form of STAT1.

• Chromatin dynamics: ChIP-seq experiments using this antibody can map genome-wide binding patterns of S727-phosphorylated STAT1 under different stimulation conditions.

What experimental designs can distinguish between STAT1α and STAT1β using Phospho-STAT1 (S727) Antibody?

Since the S727 site is present in STAT1α but deleted in STAT1β, Phospho-STAT1 (S727) Antibody can be used to distinguish between these isoforms:

• Isoform-specific detection: Phospho-STAT1 (S727) Antibody specifically detects STAT1α (91 kDa) but not STAT1β (84 kDa) when phosphorylated at S727 .

• Parallel Western blots: Running parallel Western blots with antibodies against total STAT1 (detecting both isoforms) and Phospho-STAT1 (S727) can reveal the relative expression and activation of STAT1α versus STAT1β.

• Size discrimination: In Western blotting, STAT1α appears at approximately 91 kDa, while STAT1β is approximately 84 kDa . This size difference can help distinguish the isoforms.

• Functional studies: Since S727 phosphorylation is required for full transcriptional activity, comparing gene expression changes in cells expressing only STAT1α versus STAT1β can elucidate isoform-specific functions.

• Isoform-specific knockdown: Combining isoform-specific siRNA knockdown with Phospho-STAT1 (S727) Antibody detection can confirm specificity and reveal isoform-dependent signaling effects.

How is STAT1 S727 phosphorylation involved in pathological conditions?

STAT1 S727 phosphorylation has been implicated in various pathological conditions:

• Viral infections: Altered STAT1 S727 phosphorylation may contribute to viral evasion strategies that compromise interferon responses.

• Inflammatory diseases: Dysregulated STAT1 activation, including abnormal S727 phosphorylation patterns, may contribute to chronic inflammatory conditions.

• Cancer: Both enhanced and reduced STAT1 S727 phosphorylation have been observed in different cancer types, suggesting context-dependent roles in oncogenesis and tumor suppression.

• Autoimmune disorders: Aberrant STAT1 activation and phosphorylation may contribute to the pathogenesis of autoimmune conditions by altering cytokine responsiveness.

• Metabolic diseases: Emerging evidence suggests roles for STAT1 signaling, potentially including S727 phosphorylation, in metabolic regulation and related disorders.

Studying these connections requires precise detection of phosphorylation status, making Phospho-STAT1 (S727) Antibody an essential research tool.

What are the latest findings regarding kinases responsible for STAT1 S727 phosphorylation?

Recent research has identified several kinases that can phosphorylate STAT1 at S727:

• p38 MAPK: Well-established as mediating stress-induced S727 phosphorylation independent of Y701 phosphorylation .

• CDK8: Has been implicated in IFN-γ-induced S727 phosphorylation, particularly in the context of chromatin-associated STAT1.

• PKCδ: May mediate S727 phosphorylation in response to specific stimuli, adding another layer of regulation.

• mTOR: Has been suggested to phosphorylate STAT1 S727 in certain cellular contexts, potentially linking metabolic sensing to STAT1 activation.

• Chromatin-associated kinases: Given the requirement for chromatin association prior to IFN-induced S727 phosphorylation , research is ongoing to identify chromatin-tethered kinases that might mediate this modification.

The specific kinase responsible may depend on the stimulus and cellular context, highlighting the complexity of STAT1 regulation.